Illuminating and Treating Diseases
Nuclear medicine involves the use of small amounts of radioactive materials (or tracers) to help diagnose and treat a variety of diseases. Nuclear medicine determines the cause of the medical problem based on the function of the organ, tissue or bone. This is how nuclear medicine differs from an x-ray, ultrasound or any other diagnostic test that determines the presence of disease based on structural appearance. More
September 2023
Stanford Health Care in California received Radiopharmaceutical Therapy Accreditation by SNMMI and the Intersocietal Accreditation Commission. This is the first academic facility accredited under the program, which was launched in June to recognize proficiency and competency in radiopharmaceutical therapy.
Innovations in Radiopharmaceutical Therapies - SNMMI Podcast Series
September 2023
Dr. Stephen A. Graves and Dr. Andrei Iagaru discuss the opportunities, threats, challenges, trends, and lessons learned regarding radiopharmaceutical therapy with moderator Dr. Phillip J. Koo.
To hear podcast click here
Follow-up on the Sanjiv Sam Gambhir Young Investigator Award
September 2023
Congratulations to this years winner, Victor Hvingelby!
Utilizing AI for Quantitative Assessment of Prostate Cancer Recurrence
August 2023
In a video interview, Hong Song, MD, PhD, discussed retrospective research, presented at the recent SNMMI conference, that evaluated the combination of artificial intelligence (AI)-based software and the PSMA agent piflufolastat F 18 to help quantify prostate cancer lesions and associations with biochemical progression-free survival. Congrats Hong! |
Stanford's Second Cyclotron
July 27, 2023
"Stanford Radiology reached a significant milestone with the delivery of a General Electric (GE) PETtrace 890 Cyclotron System from Sweden, across the Atlantic Ocean and United States, to 1701 Page Mill Road in Palo Alto. This new cyclotron is part of Dr. Sam Gambhir’s broader vision for precision medicine and advancements in biology and technology for better diagnosis, improved disease prevention and early intervention..." |
EANM'23: Sanjiv Sam Gambhir Young Investigator Award - TRAILER
EANM will host the 2nd Annual EANM Sanjiv Sam Gambhir Young Investigator Award. EANM has partnered with Stanford University and kindly supported by Telix Pharmaceuticals.
Please visit the EANM'23 website for detailed information by clicking here.
SNMMI Designates First Radiopharmaceutical Therapy Centers of Excellence
March 2022
"The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the Dana-Farber Brigham Cancer Center as its first two designated Radiopharmaceutical Therapy Centers of Excellence. The institutions are designated as comprehensive centers that administer multiple radiopharmaceutical therapies — such as those to treat thyroid cancer, prostate cancer and neuroendocrine tumors—and activelyengage in radiopharmaceutical therapy research. SNMMI created the Radiopharmaceutical Therapy Center of Excellence program to certify sites that meet strict regulatory, training, qualification, experience and performance criteria for radiopharmaceutical therapy. With the Radiopharmaceutical Therapy Centers of Excellence designation, institutions can assure patients, their families, referring physicians and payors that rigorous procedures are in place and followed, ultimately leading to appropriate patient selection and optimal outcomes from radiopharmaceutical therapy." |
Molecular Imaging: Principles and Practice, 2nd Edition
August 2021
On August 9th, 2021, the textbook Molecular Imaging: Principles and Practice, 2nd Edition, (Volumes 1 & 2) was published. This textbook was edited by Sanjiv Sam Gambhir, MD, PhD, and Brian Ross, PhD with contributions from Dr. Andrei Iagaru, Dr. Craig Levin & Dr. Farshad Moradi.
The detection and measurement of the dynamic regulation and interactions of cells and proteins within the living cell are critical to the understanding of cellular biology and pathophysiology. The multidisciplinary field of molecular imaging of living subjects continues to expand with dramatic advances in chemistry, molecular biology, therapeutics, engineering, medical physics and biomedical applications. Molecular Imaging: Principles and Practice, Volumes 1 and 2, Second Edition provides the first point of entry for physicians, scientists, and practitioners. This authoritative reference book provides a comprehensible overview along with in-depth presentation of molecular imaging concepts, technologies and applications making it the foremost source for both established and new investigators, collaborators, students and anyone interested in this exciting and important field.
Grand Opening of the Theragnostics Space in Nuclear Medicine
May 2021
The Division of Nuclear Medicine and Molecular Imaging held a ribbon cutting ceremony for the new Theragnostics space on May 13, 2021. This was a small gathering due to CoVID restrictions, but we were able to bring together colleagues and friends who contributed to the completion of this project. Many more watched the live streaming courtesy of Josh Mailman. It was an emotional evening as we recognized Dr McDougall's illustrious career, paid homage to Sam's vision and legacy and dedicated the newly opened area to Ross, Sam, the patients and their families.
We hope you will enjoy reading the brochure and watching the recording.
FDG: Forty Years of Changing Lives
Theragnostics Ribbon Cutting Ceremony
News
Care Award 2023
November 2023
Congratulations Christine Fujii who received the Care Award. Thank you for your commitment to achieving radiology excellence!
Service Recognition
November 2023
Thank you Lu Nguyen for the 20 years of fantastic service at SHC!
RSNA Radiology Research Resident Grant
September 2023
Wenhui Zhou, MD, PhD, Radiology Resident is the recipient of the Radiological Society of North America (RSNA) Radiology Resident Grant.
RSNA 2023 Trainee Research Prize
September 2023
Heying Duan, PhD, is the recipient of the Trainee Research Prize for the submitted research project, "Final Analysis of a Prospective, Single-center, Phase II/III Imaging Trial of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer” in the “Nuclear Medicine & Molecular Imaging” category.
Faculty Appointment
September 2023
Henry Li, MD, MS, has been appointed adjunct clinical instructor in the division of nuclear medicince.
Society of Nuclear Medicine and Molecular Imaging "Ones to Watch" 2023
August 2023
Kip Guja was recognized on SNMMI's annual list of early career professionals selected as "Ones to Watch" in 2023. Launched in 2018, SNMMI’s Ones to Watch campaign aims to recognize those with the potential to shape the future of precision medicine across all spectrums of the field. Congratulations Kip on this well deserved recognition!
2023 Alavi-Mandell Award
July, 2023
Congratulations to the recipients below who received the Alavi-Mandell Award from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for outstanding papers published in 2022 in the Journal of Nuclear Medicine. These awards are given to first authors who were trainees at the time the published work was carried out and made a major contribution to the completion of the work Heying Duan, PhD, Clinical Life Research Scientist Hong Song, MD, PhD, Assistant Professor |
SNMMI Names Helen Nadel, MD, FRCPC, as President at 2023 Annual Meeting
June 26, 2023
| Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford and clinical professor of radiology at the Stanford School of Medicine, in Stanford, California, has been named president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). |
Society of Nuclear Medicine and Molecular Imaging Announces 2023 Fellows
June 26, 2023
The Society of Nuclear Medicine and Molecular Imaging recognized ten new SNMMI Fellows today during a plenary session at the society’s 2023 Annual Meeting, held June 24-27. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is among the most prestigious formal recognitions available to long-time SNMMI members. Dr. Iagaru and Dr. Grady were recognized as two of the ten new SNMMI fellows. |
Recipient of the 2023 Mid Faculty Teaching Award, Henry Guo
June 2023
Haiwei Henry Guo, MD, PhD is a recipient of the outstanding teaching award from our residents this year. We would like to especially recognize the efforts of these faculty for their extra time and care required to create engaging lectures, share interesting cases, or elaborate on teaching points at the workstation which do not go unnoticed. We would like to acknowledge all our faculty’s dedication to teaching, and who model and mold our trainees’ thinking, behavior and attitudes to be outstanding contributors to the field and to the organization |
Craig Levin, PhD, Receives Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mars Shot Fund Award
June 2023
Craig Levin, PhD, Professor of Radiology, has been selected as the recipient of the 2023 Mars Shot Fund grant from the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The grant recognize individuals who have made transformative impact in the field and elevated the value of nuclear medicine and molecular imaging. The grant is one of five awarded in the inaugural year of the new SNMMI Mars Shot Research Fund, which was established to provide resources that translate visionary nuclear medicine imaging, radiopharmaceutical therapy and data science research or projects into tools or treatments that will help improve the lives of patients. Dr. Levin’s Mars Shot grant was awarded based on his proposal, “High-sensitivity imaging of multiple breast cancer biomarkers in a single PET/MRI imaging session.” The project will investigate and design highly innovative tools, technologies and methods that, if effective, will enhance the lives of breast cancer patients. Co-investigators include Dr. Eric Rosen, Clinical Professor of Radiology, and Dr. Corinne Beinat, Assistant Professor of Radiology. For more information about this award and the SNMMI Mars Shot Research Fund, please visit the link here. |
Recipient of the Alavi-Mandell Award, Heying Duan
May 2023
It is with great pleasure that we inform Heying Duan of being selected as a recipient of the Alavi–Mandell Award for your publication entitled, “Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer”. The Alavi-Mandell award was established by our families to honor our fathers, who valued education immensely. Unfortunately, they did not have an opportunity to reach their potential to become physician scientists. The award is given to individuals who were the first author of a paper published in the JNM, were trainees at the time the published work was carried out, and made a major contribution to the completion of the work. |